Loading…

Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics

Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS & ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience 2014-04, Vol.264, p.171-185
Main Authors: Batora, N.V, Sturm, D, Jones, D.T.W, Kool, M, Pfister, S.M, Northcott, P.A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS & ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds great promise for the future treatment of medulloblastoma.
ISSN:0306-4522
1873-7544
DOI:10.1016/j.neuroscience.2013.07.030